The Effect on methemoglobin content of hemodialysis patients with vitamin E-bonded polysulfone membrane dialyzer.

The Effect on methemoglobin content of hemodialysis patients with vitamin E-bonded polysulfone membrane dialyzer. - The Effect on methemoglobin content of hemodialysis patients with vitamin E-bonded polysulfone membrane dialyzer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014781

Enrollment

Registered

2014-09-01

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD/ESRD

Interventions

VitaminE coated dialyzer Non VitaminE coated dialyzer (APS-MD New)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult human undergoing chronic dialysis therapy

Exclusion criteria

Exclusion criteria: Administration of supplement(VitC,VitE) Existence of criticalcardiovascular complications HDF therapy or Use of &beta;2MG adsorption column

Design outcomes

Primary

Measure	Time frame
methemoglobin	—

Secondary

Measure	Time frame
CBS,Fib,TAT,CVD event, PTH-IN,Hs-CRP,AOPP, redox state of human serum albumin,MDA-LDL,vitamin E,vitamin C	—

Countries

Japan

Contacts

Public ContactTakashi Yasuda

Matsushita Memorial Hospital Department of Nephrology and artificial kidney

yasuda.takashi001@jp.panasonic.com06-6991-1231

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026